US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea (updated)

Vivos Therapeutics

29/11/2023 13:07

(Adds background and details throughout)
       Nov 29 (Reuters) - Vivos Therapeutics  VVOS.O  said on
Wednesday the U.S. health regulator has cleared its oral device
treatment for severe obstructive sleep apnea (OSA).
    The clearance is the first ever for an oral appliance, along
with a mode of respiratory ventilation or exercise training
program for the muscles around face, mouth and tongue, to treat
moderate and severe OSA in adults.
    According to Vivos, its treatment is an alternative to
therapy devices that deliver air to a mask worn by patients to
assist in breathing as well as surgically placed implants that
send electrical signals to the brain.
    

 (Reporting by Pratik Jain in Bengaluru; Editing by Shilpi
Majumdar)
 ((Pratik.Jain@thomsonreuters.com;))